Boothbay Fund Management, LLC Sutro Biopharma, Inc. Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $366,381 - $604,979	-25,711 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $58,506 - $77,569	-3,466 Reduced 11.88%	25,711 $486,000
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $134,954 - $178,292	7,485 Added 34.51%	29,177 $542,000
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $943,566 - $1.28 Million	-46,504 Reduced 68.19%	21,692 $494,000
Q4 2020 Feb 12, 2021	BUY	$10.16 - $23.98 $169,793 - $400,753	16,712 Added 32.46%	68,196 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $383,040 - $677,014	51,484 New	51,484 $517,000

137

61M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $99.1M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.